Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 9.1B | 9.3B | 8.6B | 8.4B |
Cost of revenue | 4.0B | 6.0B | 4.1B | 4.1B |
Gross profit | 5.1B | 3.3B | 4.5B | 4.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.6B | 1.5B | 1.4B | 1.2B |
Operating income | 1.5B | 2M | 1.4B | 1.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 190M | 105M | 175M | 152M |
Other income expense | — | — | — | — |
Pretax income | 1.2B | 53M | 2.6B | 1.1B |
Tax provision | -572M | -115M | 473M | 346M |
Net income | 1.8B | 168M | 2.2B | 739M |
Basic EPS | 4.8 | 1.3 | 5.5 | 2 |
Diluted EPS | 4.8 | 1.3 | 5.5 | 2 |
Basic average shares | 2.4B | 2.4B | 2.3B | 2.3B |
Diluted average shares | 2.4B | 2.4B | 2.3B | 2.3B |
EBITDA | 2.0B | 659M | 2.1B | 1.7B |
Net income from continuing op. | 1.3B | 53M | 2.6B | 1.1B |
Minority interests | -834M | 97M | -1.1B | -338M |
Preferred stock dividends | 0 | 0 | 0 | 0 |